Back
Cytokinetics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
48
CYTK
Cytokinetics, Inc.
Last Price:
$67.91
Seasonality Move:
-2.55%
7 Day Trial
ALL ACCESS PASS
$
7
Cytokinetics, Inc. Stock Forecast
-
Over the next 52 weeks, Cytokinetics, Inc. has on average historically risen by 11% based on the past 21 years of stock performance.
-
Cytokinetics, Inc. has risen higher in 10 of those 21 years over the subsequent 52-week period, corresponding to a historical accuracy of 47.62%
-
Is Cytokinetics, Inc. Stock Undervalued?The current Cytokinetics, Inc. [CYTK] share price is $67.94. The Score for CYTK is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
CYTK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Cytokinetics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Cytokinetics, Inc. has on average historically risen by 11% based on the past 21 years of stock performance.
Cytokinetics, Inc. Stock Rating
Sell
48
Cytokinetics, Inc. (CYTK)
is a Sell
Is Cytokinetics, Inc. overpriced?
-
Cytokinetics, Inc. has risen higher in 10 of those 21 years over the subsequent 52-week period, corresponding to a historical accuracy of 47.62%
Cytokinetics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
cytokinetics.com
52-Week Data
52-Week High:
70.98
52-Week Low:
29.31
Prediction Charts
Market Cap:
8.3B
Price in USD:
67.94
Volume:
2M
Beta:
1.44
Technical Analysis
SMA50:
63.71
SMA100:
62.64
SMA200:
50.00
52-Wk Change:
32.9%
Stock Predictions
-
Is Cytokinetics, Inc. stock public?Yes, Cytokinetics, Inc. is a publicly traded company.
-
What is the Cytokinetics, Inc. stock quote today?The Cytokinetics, Inc. stock price is 67.94 USD today.
-
How to buy Cytokinetics, Inc. stock online?You can buy Cytokinetics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Feb-2 | 62.10 | 65.16 | 65.63 | 62.05 |
| Feb-3 | 65.86 | 64.73 | 67.10 | 63.64 |
| Feb-4 | 64.97 | 63.52 | 65.25 | 62.35 |
| Feb-5 | 63.26 | 60.24 | 64.51 | 60.05 |
| Feb-6 | 61.31 | 62.34 | 62.74 | 61.00 |
| Feb-9 | 62.21 | 63.36 | 63.68 | 61.58 |
| Feb-10 | 63.96 | 64.85 | 65.49 | 63.13 |
| Feb-11 | 65.25 | 66.80 | 66.98 | 63.53 |
| Feb-12 | 67.00 | 65.04 | 67.89 | 64.64 |
| Feb-13 | 65.49 | 66.26 | 67.54 | 64.58 |
| Feb-17 | 65.98 | 66.62 | 66.99 | 65.51 |
| Feb-18 | 66.31 | 66.98 | 67.67 | 66.01 |
| Feb-19 | 66.61 | 67.83 | 67.86 | 65.54 |
| Feb-20 | 67.72 | 67.94 | 69.12 | 67.45 |
Cytokinetics, Inc. Earnings
Cytokinetics, Inc. Earnings Report: Per Share Cytokinetics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Cytokinetics, Inc. Forecast Revenue Growth
Cytokinetics, Inc. Stock Analysis: Historical quarterly revenues per share for Cytokinetics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.15 per share, and an increase next year of $2.15 per share.
* Cytokinetics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.